SOX2 and central nervous system cancer: By utilizing the canonical markers SOX2 and PTPRZ1 which were overexpressed in glioma cells15, C5 (glial cells) and C17 (astrocytes) exhibited low or no expression and were considered as benign clusters (Fig. 3b; Supplementary Fig. S4a).